Neurovascular Devices Market by Device Type (Neurothrombectomy, Cerebral Angioplasty & Stenting Systems, Others), Therapeutic Application, Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2019 to 2026
Published On: July 2019
 
Report ID:399156
 
Category: Healthcare
 
Pages: 250




Global neurovascular devices market is expected to reach USD 3.48 Billion by 2026, at a CAGR of 5.97% from 2019 to 2026. Growing preference for the minimally invasive surgeries, global increase in geriatric population and favorable medical reimbursement conditions are driving the global neurovascular devices market.

Market Overview:

Neurovascular devices are mainly used in the surgery, diagnosis and treatment of various neurological diseases. These devices are immensely used in the treatment and diagnosis of all categories of diseases and conditions involving the peripheral and central nervous system. Neurovascular devices aid in the treatment of various neurovascular disorders such as cerebral aneurysms and intracranial atherosclerotic disease. Thus, the rising incidence of the neurological disorders coupled with a growing demand for effective neurovascular devices are expected to drive the market growth over the forecast period.

Report Description:

  • The base year for the study has been considered 2018, historic year 2016 and 2017 and, the forecast period considered is from 2019 to 2026. The global neurovascular devices market is analysed on the basis of value (USD Billion) volume (Thousand Units), consumption (Thousand Units), imports (Thousand Units) and exports (Thousand Units).
  • The study delivers a comprehensive analysis of global neurovascular devices market by device type, therapeutic application and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global neurovascular devices market. This report incorporates the industry analysis which is focused on providing an extensive view of the neurovascular devices market.
  • The study also includes attractiveness analysis of device type, therapeutic application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the neurovascular devices market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Global increase in geriatric population
  • Increasing prevalence of neurovascular disorders
  • Favorable medical reimbursements regulations
  • Growing market demand for effective neurovascular devices

Restrains:

  • Stringent regulatory approval process
  • Paucity of skilled neurosurgeons

Opportunities:

  • Increasing research activity in the field of neurovascular therapies
  • Growing preference for the minimally invasive neurosurgical procedures
  • Growing awareness among neurosurgeons about minimally invasive surgical procedures

Challenges:

  • High cost of the surgery

Global Neurovascular Devices Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global Neurovascular Devices market has been segmented on the basis of device type, and therapeutic application.

  • Device type segment is divided into cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, and support devices. The cerebral embolization and aneurysm coiling devices segment led the global market with a 38.74% share of market revenue in 2018. This increased market share can be attributed to the large number of people undergoing neurological surgery as well as availability of these products in various lengths and volumes.
  • The therapeutic application segment includes stroke, cerebral artery stenosis, cerebral aneurysm, others. The cerebral aneurysm segment is anticipated to grow at an accelerated CAGR of 8.04% over the forecast period. Growing prevalence of the cerebral aneurysms along with its treatment with the help of embolizing coils and stents are expected to fuel this growth over the forecast period.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. The North America region emerged as the largest market for the neurovascular devices with a 42.18% share of market revenue in 2018.

  • Presence of well-developed healthcare facilities, high incidence rate of the neurological stroke along with favorable reimbursement structure and availability of advanced technologies with higher efficiency and reliability led the North America region to dominate the global demand for the neurovascular devices in 2018.
  • The Asia Pacific region is projected to grow at the highest CAGR of 8.24% over the forecast period. Growing awareness pertaining to neurovascular disorders and its management, rapid improvement in the standard of healthcare facilities are some of the factors that are expected to drive this increased growth rate. 

Global Neurovascular Devices Market Competitive Analysis:

Key players in the global neurovascular devices market are Abbott Laboratories, W. L. Gore & Associates, Inc., Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corp., Terumo Medical Corporation, Integer Holdings Corporation, and Acandis GmbH & Co. KG among others. Major players are focusing on new product launch in order to effectively participate in the highly competitive market. For instance in 2016, Penumbra, Inc. launched ACE 68 Reperfusion Catheter for the treatment of acute ischemic stroke. It includes latest technological advancements to deliver maximum aspiration power for extracting thrombus in acute ischemic stroke patients.

*All our reports are customizable as per customer requirements

This study forecasts revenue and volume growth at global, regional, and country levels from 2016 to 2026. Fior Market Research has segmented the global neurovascular devices market on the basis of below mentioned segments:

Global Neurovascular Devices Market by Device Type:

  • Cerebral Embolization and Aneurysm Coiling Devices
  • Cerebral Angioplasty and Stenting Systems
  • Neurothrombectomy Devices
  • Support devices

Global Neurovascular Devices Market by Therapeutic Application:

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

Global Neurovascular Devices Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa         
    • UAE
    • South Africa
  1. INTRODUCTION
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. RESEARCH SCOPE
    4. CURRENCY
  2. RESEARCH METHODOLOGY AND ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. TOP INVESTMENT POCKETS
      1. MARKET ATTRACTIVENESS ANALYSIS BY DEVICE TYPE
      2. MARKET ATTRACTIVENESS ANALYSIS BY THERAPEUTIC APPLICATION
      3. MARKET ATTRACTIVENESS ANALYSIS BY REGION
    2. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF SUPPLIERS
      4. BARGAINING POWER OF BUYERS
      5. INTENSITY OF COMPETITIVE RIVALRY
    3. PESTEL ANALYSIS
    4. INDUSTRY SWOT ANALYSIS
    5. INDUSTRY TRENDS
    6. MICRO AND MACRO FACTORS AFFECTING GLOBAL NEUROVASCULAR DEVICES MARKET
    7. PRICING ANALYSIS
      1. PRICING ASSUMPTIONS
      2. PRICE PROJECTIONS PER REGION
    8. MACRO-ECONOMIC FACTORS
      1. SUPPLY SIDE
      2. DEMAND SIDE
    9. TRADE MAP ANALYSIS (IMPORT-EXPORT DATA)
    10. COUNTRY LEVEL ANALYSIS
    11. PENETRATION & GROWTH PROSPECT MAPPING
    12. INDUSTRY VALUE CHAIN ANALYSIS
      1. RAW MATERIALS ANALYSIS
      2. SUPPLIER ANALYSIS
      3. END USER ANALYSIS
    13. CUSTOMERS/BUYERS BY REGIONS
  5. MARKET DYNAMICS
    1. MARKET EVALUATION
    2. DRIVERS
      1. GLOBAL INCREASE IN GERIATRIC POPULATION
      2. INCREASING PREVALENCE OF NEUROVASCULAR DISORDERS
      3. FAVORABLE MEDICAL REIMBURSEMENTS REGULATIONS
      4. GROWING MARKET DEMAND FOR EFFECTIVE NEUROVASCULAR DEVICES
    3. RESTRAINS
      1. STRINGENT REGULATORY APPROVAL PROCESS
      2. PAUCITY OF SKILLED NEUROSURGEONS
    4. OPPORTUNITIES
      1. INCREASING RESEARCH ACTIVITY IN THE FIELD OF NEUROVASCULAR THERAPIES
      2. GROWING PREFERENCE FOR THE MINIMALLY INVASIVE NEUROSURGICAL PROCEDURES
      3. GROWING AWARENESS AMONG NEUROSURGEONS ABOUT MINIMALLY INVASIVE SURGICAL PROCEDURES
    5. CHALLENGES
      1. HIGH COST OF THE SURGERY
  6. GLOBAL NEUROVASCULAR DEVICES MARKET ANALYSIS AND FORECAST, BY DEVICE TYPE
    1. SEGMENT OVERVIEW
    2. CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES
    3. CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS
    4. NEUROTHROMBECTOMY DEVICES
    5. SUPPORT DEVICES
  7. GLOBAL NEUROVASCULAR DEVICES MARKET ANALYSIS AND FORECAST, BY THERAPEUTIC APPLICATION
    1. SEGMENT OVERVIEW
    2. STROKE
    3. CEREBRAL ARTERY STENOSIS
    4. CEREBRAL ANEURYSM
    5. OTHERS
  8. GLOBAL NEUROVASCULAR DEVICES MARKET ANALYSIS AND FORECAST, BY REGIONAL ANALYSIS
    1. SEGMENT OVERVIEW
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. FRANCE
      3. U.K.
      4. ITALY
      5. SPAIN
      6. REST OF EUROPE
    4. ASIA-PACIFIC
      1. JAPAN
      2. CHINA
      3. INDIA
      4. REST OF APAC
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF SA
    6. MIDDLE EAST AND AFRICA
      1. UAE
      2. SOUTH AFRICA
      3. REST OF MEA
  9. GLOBAL NEUROVASCULAR DEVICES MARKET-COMPETITIVE LANDSCAPE
    1. OVERVIEW
    2. MARKET SHARE OF KEY PLAYERS IN THE NEUROVASCULAR DEVICES MARKET
      1. GLOBAL COMPANY MARKET SHARE
      2. NORTH AMERICA COMPANY MARKET SHARE
      3. EUROPE COMPANY MARKET SHARE
      4. APAC COMPANY MARKET SHARE
    3. COMPETITIVE SITUATIONS AND TRENDS
      1. DEVICE TYPE LAUNCHES AND DEVELOPMENTS
      2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
      3. MERGERS & ACQUISITIONS
      4. EXPANSIONS
  10. COMPANY PROFILES
    1. ABBOTT LABORATORIES
      1. BUSINESS OVERVIEW
      2. COMPANY SNAPSHOT
      3. KEY FINANCIAL
        1. REVENUE ANALYSIS
        2. PRICE ANALYSIS
        3. COST ANALYSIS
        4. VOLUME ANALYSIS
        5. MARGIN ANALYSIS
        6. COMPANY SEGMENT ANALYSIS
      4. COMPANY PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
      6. SWOT ANALYSIS
    2. W. L. GORE & ASSOCIATES, INC
    3. JOHNSON & JOHNSON
    4. MEDTRONIC PLC
    5. MERIT MEDICAL SYSTEMS, INC
    6. MICROPORT SCIENTIFIC CORPORATION
    7. PENUMBRA, INC
    8. STRYKER CORP
    9. TERUMO MEDICAL CORPORATION
    10. INTEGER HOLDINGS CORPORATION
    11. ACANDIS GMBH & CO. KG

LIST OF TABLE

  1. GLOBAL NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  2. GLOBAL CEREBRAL EMBOLIZATION AND ANEURYSM COILING NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  3. GLOBAL CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  4. GLOBAL NEUROTHROMBECTOMY NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  5. GLOBAL SUPPORT DEVICES NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  6. GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  7. GLOBAL STROKE NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  8. GLOBAL CEREBRAL ARTERY STENOSIS NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  9. GLOBAL CEREBRAL ANEURYSM NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  10. GLOBAL OTHERS NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  11. GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  12. GLOBAL NEUROVASCULAR DEVICES MARKET, BY NORTH AMERICA, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  13. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  14. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  15. U.S. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  16. U.S. NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  17. CANADA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  18. CANADA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  19. MEXICO NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  20. MEXICO NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  21. EUROPE NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  22. EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  23. GERMANY NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  24. GERMANY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  25. FRANCE NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  26. FRANCE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  27. U.K. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  28. U.K. NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  29. ITALY NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  30. ITALY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  31. SPAIN NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  32. SPAIN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  33. ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  34. ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  35. JAPAN NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  36. JAPAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  37. CHINA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  38. CHINA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  39. INDIA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  40. INDIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  41. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  42. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  43. BRAZIL NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  44. BRAZIL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  45. MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  46. MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  47. UAE NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  48. UAE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  49. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  50. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)

LIST OF FIGURES 

  1. GLOBAL NEUROVASCULAR DEVICES  MARKET SEGMENTATION
  2. NEUROVASCULAR DEVICES  MARKET: RESEARCH METHODOLOGY
  3. MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  4. MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  5. DATA TRIANGULATION
  6. PORTER’S FIVE FORCES ANALYSIS
  7. VALUE CHAIN ANALYSIS
  8. GLOBAL NEUROVASCULAR DEVICES MARKET ATTRACTIVENESS ANALYSIS BY DEVICE TYPE
  9. GLOBAL NEUROVASCULAR DEVICES MARKET ATTRACTIVENESS ANALYSIS BY THERAPEUTIC APPLICATION
  10. GLOBAL NEUROVASCULAR DEVICES MARKET ATTRACTIVENESS ANALYSIS BY REGION
  11. GLOBAL NEUROVASCULAR DEVICES MARKET: DYNAMICS
  12. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY DEVICE TYPE (2018 & 2026)
  13. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY THERAPEUTIC APPLICATION (2018 & 2026)
  14. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY REGIONS (2018 & 2026)
  15. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY COMPANY (2019)


Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.